China's Giant Biogene shares to open 7% higher in Hong Kong IPO
04/11/2022 01:20
Nov 4 (Reuters) - China's Giant Biogene 2367.HK shares
are set to rise 7% when the company debuts on the Hong Kong
Stock Exchange on Friday, after it raised $70 million in its
initial public offering.
The company sold 22.6 million shares at HK$24.30 each and
the stock is due to open at HK$26.
(Reporting by Scott Murdoch and Donny Kwok; Editing by Tom
Hogue)
((Scott.Murdoch@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan